PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV

I Stopped Mounjaro After 545 Days & £3000 — Here's Why

24:47May 2026

Today’s cheapest tirzepatide$69/mo at Wellmedr, sale price.Compare all tirzepatide prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

In this weekly update, the speaker of the channel says he has stopped Mounjaro after 545 days. He says he lost four stone (56 lb, around 25 kilos) and spent close to £3,000, possibly more, since prices changed so much. He gives several reasons: the cost feels harder to justify now that his loss has slowed, his partner has long been worried about the long-term data and asked him not to move up to 10 mg, and he had his first severe stomach aches after moving to 7.5 mg. He also reports feeling hunger on the medication for the first time and wanting to see whether his own habits can carry him to his goal of 16 stone.

Published by Phill Double L on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

He responds to viewers who said he was dragging the channel out for money, saying his earnings went back into equipment and software and do not cover his monthly Mounjaro cost. He says the channel will continue with news, advice videos and community discussion. He reads viewer comments, several of which say 7.5 mg worked poorly for them, one about regaining hunger and food noise after stopping, one asking whether to move from 5 mg to 7.5 mg, and one about asthma improving. Sylvia and Bo also describe the new Mounjaro QuickPens.

The news section covers Canada approving a second generic semaglutide, Novo Nordisk rebranding its diabetes pill as the Ozempic pill in the US, and an FDA report of liver failure in a patient taking Eli Lilly's pill, which he says he will research further. In his weekly results, he went from 16 stone 8 lb to 16 stone 6 lb, a 2 lb loss, which he says he takes with caution because he barely ate for three or four days. He is about ten days past his last injection and says food noise has not returned.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:30 The speaker says he is stopping Mounjaro mainly because of cost, his partner's health concerns, and what he calls a very slow rate of loss on 7.5 mg.
  2. 6:32 He says severe stomach aches after moving to 7.5 mg and hunger for the first time on the medication tipped his decision.
  3. 9:00 About 10 days after his last injection, he reports occasional hunger but no return of food noise, and he uses water and routines to cope.
  4. 14:44 Viewer comments describe 7.5 mg as a weak dose for several people, and one viewer asks about regaining hunger after stopping.
  5. 18:47 News covers a second generic semaglutide approved in Canada, the Ozempic pill rebrand in the US, and an FDA liver failure report involving Eli Lilly's pill.
  6. 22:20 His final Mounjaro weekly result is 16 stone 6 lb, down 2 lb, with about 6 lb to go to his 16 stone goal by the end of May.

Key moments

Tap one to play from there.

  1. 0:00 Intro
  2. 0:25 Waffle Section
  3. 14:28 Viewer Comments
  4. 18:57 News
  5. 22:04 Weekly Update
  6. 23:24 Weekly Result

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Ozempic, Wegovy, Mounjaro and Rybelsus

Questions this video answers

Why did the speaker stop taking Mounjaro?

He says the cost felt too high for the small losses he was getting on 7.5 mg, his partner was worried about long-term effects, and he had severe stomach aches after the dose increase. He also says he felt hunger for the first time on the medication and wanted to see if his habits could keep him going.

How much weight did the speaker lose on Mounjaro and how much did it cost?

He says he lost four stone (56 lb, around 25 kilos) over 545 days, though he regained some of it. He estimates he spent close to £3,000, possibly more, because prices changed over the period.

What happened in the first days after stopping Mounjaro?

The speaker says that about 10 days after his last injection he had occasional hunger but no food noise. He says he drank water instead of snacking, and that his week's weigh-in went from 16 stone 8 lb to 16 stone 6 lb, which he treats cautiously because he ate very little for three or four days.

What do viewers say about the 7.5 mg Mounjaro dose?

According to the comments the speaker reads, Mikey and Julie both say 7.5 mg did little for them, with Mikey reporting weak appetite suppression and the most side effects. The speaker says many viewers said similar things about that dose.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Mounjaro vs Ozempic, and the trial everyone quotes about it

    Mounjaro is tirzepatide and Ozempic is semaglutide: different molecules, not two brands of the same drug. Both are approved for type 2 diabetes, and the weight-loss versions are Zepbound and Wegovy. In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. The detail almost every page omits: that trial dosed semaglutide to 2.4 mg in people without diabetes, which is the Wegovy range. Ozempic tops out at 2 mg. The famous result did not test Ozempic's dose range.

  • Mounjaro for weight loss, and why Zepbound exists

    Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same maker, approved for weight management, and it goes to the same 15 mg. So unlike Ozempic and Wegovy, there is no dose ceiling pushing you from one to the other: the reason people move is coverage and cash price, not strength. Using Mounjaro for weight is off-label and a prescriber's decision. In the one head-to-head trial, tirzepatide beat semaglutide, 20.2% mean body-weight loss at 72 weeks against 13.7%.

  • Mounjaro side effects: the label's numbers by dose, the low blood sugar risk, and how tirzepatide compares at weight-loss doses

    On Mounjaro's own label, the common side effects are stomach ones and they rise with the dose: nausea in 12, 15 and 18 percent of people at 5, 10 and 15 mg against 4 percent on placebo, diarrhea 12 to 17 against 9, and any gastrointestinal reaction in 37 to 44 percent against 20. Most of it happens while the dose is being raised and fades. Low blood sugar is rare on Mounjaro alone and is mainly a risk when it is added to insulin or a sulfonylurea. Below: the full table, the rare warnings, and why Zepbound's numbers for the same molecule look higher.

Next steps

Mounjaro prices

Insurance

Find more like it

Side effectsDose changeWeigh-in and resultsFood, protein and eatingFood noise and cravingsCost and insuranceExercise and strengthAlcoholStopping and maintenance

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV